Organigram Global Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OGI research report →
Companywww.organigram.ca
Organigram Holdings Inc. , through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co.
- CEO
- James H. Yamanaka
- IPO
- 2019
- Employees
- 1,093
- HQ
- Moncton, NB, CA
Price Chart
Valuation
- Market Cap
- $145.88M
- P/E
- -7.78
- P/S
- 0.74
- P/B
- 0.53
- EV/EBITDA
- -3.85
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -3.07%
- Op Margin
- -38.62%
- Net Margin
- -9.19%
- ROE
- -6.83%
- ROIC
- -15.84%
Growth & Income
- Revenue
- $186.09M · 16.42%
- Net Income
- $-17,776,962 · 60.88%
- EPS
- $-0.14 · 70.83%
- Op Income
- $-63,405,144
- FCF YoY
- -1027.05%
Performance & Tape
- 52W High
- $2.24
- 52W Low
- $1.04
- 50D MA
- $1.36
- 200D MA
- $1.57
- Beta
- 1.91
- Avg Volume
- 695.67K
Get TickerSpark's AI analysis on OGI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our OGI Coverage
We haven't published any research on OGI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate OGI Report →